Pinprick diagnostics
Nature2012Vol. 486(7404), pp. 482–483
Citations Over TimeTop 13% of 2012 papers
Related Papers
- → Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab(2008)47 cited
- → Treatment with Panitumumab After a Severe Infusion Reaction to Cetuximab in a Patient with Metastatic Colorectal Cancer: A Case Report(2007)45 cited
- → The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience(2020)2 cited
- → The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic(2017)
- ASPECCT: panitumumab versus cetuximab for colorectal cancer(2014)